Potential Drug Interactions Associated with Treatments for Type 2 Diabetes and its Comorbidities: A Clinical Pharmacology Review

Document Type

Article

Publication Date

1-1-2012

Abstract

Type 2 diabetes is a disease of glucose metabolism that commonly involves multiple comorbidities, including lipid dyscrasias and hypertension. Each concurrent disorder contributes some risk of complications and requires therapeutic intervention. The simultaneous management of so many coexisting illnesses can be complex and commonly results in patients being prescribed multiple medications--referred to as polypharmacy--which may further complicate treatment. To ensure the best patient outcomes, the treating physician must be aware of all the therapeutic agents that a patient is taking to assess possible drug interactions that such a plethora of medications may confer. This article addresses the underlying comorbidites, the drugs commonly used to treat them and the interactions that may arise from concomitant administration.

Publication Title

Expert Review of Clinical Pharmacology

Volume

5

Issue

1

First Page

31

Last Page

42

PubMed ID

22142157

Comments

This article was published in Expert Review of Clinical Pharmacology, Volume 5, Issue 1, January 2012, Pages 31-42.

The published version is available at http://dx.doi.org/10.1586/ecp.11.64

Copyright 2012 © Informa Healthcare

This document is currently not available here.

COinS